Histerektomi materyallerinde adenomyozis sıklığının araştırılması

Amaç: Histerektomi materyallerinde adenomyozis sıklığının saptanması amaçlanmıştır. Gereç ve Yöntemler: Çalışmamızda Sarahatun Kadın Hastalıkları ve Doğum Kliniği'nde bening nedenlerle total abdominal ve vaginal histerektomi yapılan 241 hastanın postoperatif histerektomi materyallerinin histopatolojik değerlendirmelerinde adenomyozis sıklığı ve bu vakaların demografik özellikleri incelendi. Bulgular: Bu çalışmada toplam 241 histerektomi materyali incelendi ve 52 tanesinde (%21,6) adenomyozis varlığı tespit edildi. Sonuç: Adenomyozis tanısı, değişik nedenlerle kliniğe başvuran hastalarda tedavi planlaması esnasında akılda tutulmalıdır.

Determination of adenomyosis incidence in hysterectomy materials

Objective: To determine the frequency of adenomyosis in hystrectomy materials. Materials and Methods: We herein analyse the adenomyozis frequency in histopathologic evaluation of 241 abdominal and vaginal hysterectomy materials performed due to bening causes in Sarahatun Obstetric and Gynecology Clinic and demographic properties of these patients are evaluated. Results: 241 hysterectomy materials are evaluated in this study and 52 adenomyosis (%21.6) case are determined. Conclusion: Adenomyosis must be remembered in mind in patients admitted to clinic due to different causes and before managing treatment.

PDF

___

1) Zaloudek C, Hendrickson MR. Mesenchymal tumors of the uterus. In Blausteins' pathology of the female genital tract. Kurman RJ ed. Fifth edition, New York: Springer, 2002: 561-573.
2) Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998; 4: 312-22.
3) Kumar V, Cotran R, Robbins SL. Basic Pathology. Fifith edition, Philadelphia: W.B. Saunders, 1992: 615-616.
4) Pernoll ML. Obstetrik ve Jinekoloji El Kitabı. Ayhan A (Çeviren). 10. baskı, Ankara: Palme, 2002: 755-767.
5) Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod. 1997; 12: 1275-1279.
6) Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gynecol. 2005; 17: 261-264.
7) Atri M, Reinhold C, Mehio AR, Chapman WB, Bret PM. Adenomyozis: US features with histologic correlation in an in vitro study. Radiology. 2000; 215: 783-790.
8) Speroff L, Fritz MA. Klinik Jinekolojik Endokrinoloji ve İnfertilite. Erk A, Günalp S (Çeviren). 7. baskı, Ankara: Güneş Tıp Kitabevi, 2007: 562-605.
9) Ayhan A. Kadın Hastalıkları ve Doğum Bilgisi. 2. baskı, Ankara: Güneş Tıp Kitabevi, 2008: 969-981.
10) Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005; 20: 2309-2316.
11) Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20: 603-616.
12) Azziz R. Adenomyosis in pregnancy. J. Reprod. Med.1986; 31: 224-227.
13) McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update, 1998; 4: 350-359.
14) Wood C, Maher P, Hill D. Biopsy diagnosis and conservative surgical treatment of adenomyosis. Aust N Z J Obstet Gynaecol, 1993; 33: 319-321.
15) Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception, 1999; 60: 173-175.
16) Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception, 2009 ; 79: 189-193.
17) Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril, 2000; 74: 412-413.
18) Shawki OA. Danazol loaded intrauterine device D-IUD: a novel conservative management for uterine adenomyosis. Middle East Fertility Society Journal. 2002; 7: 214-220.
19) Huang WS, Ynag TS, Yuan CC. Successful pregnancy after treatment of deep adenomyosis with cytoreductive surgery and subsequent gonadotropin-releasing hormone agonist: a case report. Chin Med J. 1998; 61: 726-729.
20) Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis and infertility. Chin Med J. 2000; 113: 442-445.